Agenda Details

An array of exciting new cell- and gene-based approaches are being developed for therapeutic discovery and potential treatment of heart and blood vessel diseases. This session will profile four examples of such emerging technologies: 1) gene editing to correct vascular smooth muscle dysfunction, 2) gene therapy to enhance the contractility of failing hearts, 3) gene therapy to promote myocardial regeneration via reactivation of cardiomyocyte proliferation, and 4) viral vectors engineered to enable selective targeting of specific (e.g., cerebral) blood vessel types.